The research aims to assess the effectiveness of a CT-based radiomic model in predicting treatment response to neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma.
Developed a radiomic model using preoperative CT scans.
Validated the model across multiple centers.
Compared prediction accuracy with conventional methods.
The radiomic model accurately predicted treatment responses.
Validation across multicenter groups confirmed its reliability.
Enhanced treatment planning was suggested based on predictions.
Abstract
A preoperative CT–based radiomic model effectively predicted neoadjuvant chemoimmunotherapy response in patients with esophageal squamous cell carcinoma, as validated across multicenter groups.